This confirms the repressive effect of NFIB over SOX2 expression and illustrates a potential mechanism upstream of SOX2 that modulates chromatin accessibility at the SRR124–134 cluster and subsequent control of SOX2 transcription in cancer cells. The gene discussed is NFIB; the disease is cancer.